ALateral Flow Assay to Detect QSOX1 Peptide in Patients With or at Risk for Pancreatic Cancer
NCT04064034
Cysts, Digestive System Diseases
Scottsdale, Arizona, United States
View Trial DetailsNCT Number: NCT02703545
Various centers around the world are currently investigating the feasibility and yield of surveillance for pancreatic cancer in high-risk individuals. Evidence is beginning to accumulate that surveillance may lead to the early detection of non-invasive precursor lesions and asymptomatic early stage cancer. Ultimately, the goal of surveillance is to reduce mortality in these high risk individuals, but before this can be confirmed many research questions need to be answered. While the numbers of high-risk individuals screened in each separate screening facility are likely too small to properly address many of these questions, pooling data comprises a sizable sample size providing unique research opportunities. The objective of this study is retrospectively review all cases of high-risk individuals participating in our pancreatic surveillance program in whom 1) a suspicious precursor lesions was detected for which a pancreatic resection was performed and 2) in whom an advanced malignant disease was diagnosed. The de-identified information will be entered into an international multicenter database registry.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
The study is a retrospective review of all cases of high-risk individuals participating in our pancreatic surveillance program in whom 1) a suspicious precursor lesions was detected for which a pancreatic resection was performed and 2) in whom an advanced malignant disease was diagnosed. The de-identified information will be entered into an international multicenter database registry.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 5 years
Prevalence of pancreatic neoplasia high risk patients who had surgery for detected lesions in screening programs
Time frame: 5 years
Pathology or imagining related to surgery indication
Time frame: 5 years
Time frame: 5 years
Proportion of patients who had surgery or biopsy for new pancreatic lesions on follow-up
Time frame: 5 years
Time frame: 5 years
Johns Hopkins University
Other
International CAPS Registry: Operated Cases and Cases With Advanced Disease Among High-risk Individuals Participating in a Pancreatic Cancer Surveillance Program; a Case-control Study
Acronym: CAPS Registry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04064034
Cysts, Digestive System Diseases
Scottsdale, Arizona, United States
View Trial DetailsNCT03172572
Cysts, Digestive System Diseases
Amsterdam, Netherlands
View Trial DetailsNCT00680420
Cysts, Digestive System Diseases
Portland, Oregon, United States
View Trial DetailsNCT04970056
Cysts, Digestive System Diseases
Phoenix, Arizona, United States
View Trial Details